Can zapping tumors with surgery or radiation boost lung cancer treatment?
NCT ID NCT06114108
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with advanced stage IV non-small cell lung cancer that has spread. After standard therapy (chemo, immunotherapy, or targeted drugs) works well, some will also get surgery or radiation on remaining tumors. The goal is to see if this extra treatment helps keep cancer from growing longer and maintains quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Hôpital Fribourgeois - Hôpital Cantonal
RECRUITINGFribourg, Switzerland
-
Hôpitaux Universitaires Genève HUG
RECRUITINGGeneva, 1205, Switzerland
-
IOSI Ospedale Regionale di Bellinzona e Valli
RECRUITINGBellinzona, 6500, Switzerland
-
Kantonspital Aarau
RECRUITINGAarau, 5001, Switzerland
-
Kantonsspital Graubuenden
RECRUITINGChur, CH-7000, Switzerland
-
Luzerner Kantonsspital
RECRUITINGLucerne, Switzerland
-
Universitätsspital Zürich
RECRUITINGZurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Direct-to-Tumor chemo blast halt advanced lung cancer?
- Smart patch and app aim to boost lung recovery after cancer surgery
- Targeted drug LDK378 takes aim at rare ROS1-driven lung cancer
- Custom-Made vaccine aims to stop lung cancer recurrence
- Radiation and immunotherapy combo before lung cancer surgery shows promise in early trial
- New study aims to tame cholesterol side effect of lung cancer drug